BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11581607)

  • 1. Recombinant human erythropoietin administration in cardiac surgery.
    Yazicioğlu L; Eryilmaz S; Sirlak M; Inan MB; Aral A; Taşöz R; Eren NT; Kaya B; Akalin H
    J Thorac Cardiovasc Surg; 2001 Oct; 122(4):741-5. PubMed ID: 11581607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study.
    Weltert L; D'Alessandro S; Nardella S; Girola F; Bellisario A; Maselli D; De Paulis R
    J Thorac Cardiovasc Surg; 2010 Mar; 139(3):621-6; discussion 626-7. PubMed ID: 20042202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autologous blood donation with recombinant human erythropoietin prior to elective cardiac surgery in anemic patients].
    Kiyama H; Ohshima N; Imazeki T; Yamada T
    Kyobu Geka; 1998 Aug; 51(9):741-4. PubMed ID: 9742815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of preoperative treatment with recombinant human erythropoietin in patients undergoing hemodilutional autologous transfusion].
    Nakae Y; Sonoda H; Miyabe M; Kawamata M; Sakakibara N; Kawana S; Namiki A
    Masui; 1995 Oct; 44(10):1362-8. PubMed ID: 8538004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery.
    Braga M; Gianotti L; Gentilini O; Vignali A; Di Carlo V
    Hepatogastroenterology; 1997; 44(15):685-90. PubMed ID: 9222672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of human recombinant erythropoietin on reduction of homologous blood transfusion in open-heart surgery. A Japanese Multicenter study.
    Kyo S; Omoto R; Hirashima K; Eguchi S; Fujita T
    Circulation; 1992 Nov; 86(5 Suppl):II413-8. PubMed ID: 1424032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of recombinant erythropoietin for stimulating erythropoiesis after blood loss and surgery. An experimental study in rats.
    Hoynck van Papendrecht MA; Jeekel H; Busch OR; Marquet RL
    Eur J Surg; 1992 Feb; 158(2):83-7. PubMed ID: 1350220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
    Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
    Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant human erythropoietin on anaemia after gastrectomy: a pilot study.
    Tsuji Y; Kambayashi J; Shiba E; Sakon M; Kawasaki T; Mori T
    Eur J Surg; 1995 Jan; 161(1):29-33. PubMed ID: 7727602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
    Vanstraelen G; Baron F; Willems E; Bonnet C; Hafraoui K; Frère P; Fillet G; Beguin Y
    Exp Hematol; 2006 Jul; 34(7):841-50. PubMed ID: 16797411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery.
    Yoo YC; Shim JK; Kim JC; Jo YY; Lee JH; Kwak YL
    Anesthesiology; 2011 Nov; 115(5):929-37. PubMed ID: 22027622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
    Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants.
    Fauchère JC; Dame C; Vonthein R; Koller B; Arri S; Wolf M; Bucher HU
    Pediatrics; 2008 Aug; 122(2):375-82. PubMed ID: 18676556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of preoperative administration of a single dose of recombinant human erythropoietin in pediatric cardiac surgery.
    Ootaki Y; Yamaguchi M; Yoshimura N; Oka S; Yoshida M; Hasegawa T
    Heart Surg Forum; 2007; 10(2):E115-9. PubMed ID: 17597033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
    Baron F; Frère P; Fillet G; Beguin Y
    Clin Cancer Res; 2003 Nov; 9(15):5566-72. PubMed ID: 14654537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of preoperative erythropoietin administration in pediatric neuromuscular scoliosis patients.
    Vitale MG; Privitera DM; Matsumoto H; Gomez JA; Waters LM; Hyman JE; Roye DP
    Spine (Phila Pa 1976); 2007 Nov; 32(24):2662-7. PubMed ID: 18007241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery.
    Cuenca J; García-Erce JA; Martínez F; Pérez-Serrano L; Herrera A; Muñoz M
    Transfusion; 2006 Jul; 46(7):1112-9. PubMed ID: 16836557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety.
    Juul SE; McPherson RJ; Bauer LA; Ledbetter KJ; Gleason CA; Mayock DE
    Pediatrics; 2008 Aug; 122(2):383-91. PubMed ID: 18676557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.